| The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease H Hampel, MM Mesulam, AC Cuello, MR Farlow, E Giacobini, ... Brain 141 (7), 1917-1933, 2018 | 1670 | 2018 |
| The amyloid-β pathway in Alzheimer’s disease H Hampel, J Hardy, K Blennow, C Chen, G Perry, SH Kim, VL Villemagne, ... Molecular Psychiatry 26 (10), 5481-5503, 2021 | 1269 | 2021 |
| The β-secretase BACE1 in Alzheimer’s disease H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ... Biological psychiatry 89 (8), 745-756, 2021 | 595 | 2021 |
| Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 382 | 2019 |
| Revisiting the cholinergic hypothesis in Alzheimer’s disease: emerging evidence from translational and clinical research H Hampel, MM Mesulam, AC Cuello, AS Khachaturian, A Vergallo, ... The journal of prevention of Alzheimer's disease 6, 2-15, 2019 | 342 | 2019 |
| A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease H Hampel, F Caraci, AC Cuello, G Caruso, R Nisticò, M Corbo, F Baldacci, ... Frontiers in immunology 11, 456, 2020 | 284 | 2020 |
| Developing the ATX (N) classification for use across the Alzheimer disease continuum H Hampel, J Cummings, K Blennow, P Gao, CR Jack Jr, A Vergallo Nature Reviews Neurology 17 (9), 580-589, 2021 | 267 | 2021 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 158 | 2019 |
| Early Detection of Mild Cognitive Impairment (MCI) in Primary Care MN Sabbagh, M Boada, S Borson, M Chilukuri, B Dubois, J Ingram, ... The Journal of Prevention of Alzheimer’s Disease (JPAD), 2020 | 156 | 2020 |
| Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology J Alzheimers Dis 64 (s1), S47-S105, 0 | 155* | |
| Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence H Hampel, R Nisticò, NT Seyfried, AI Levey, E Modeste, P Lemercier, ... Ageing Research Reviews 69, 101346, 2021 | 118 | 2021 |
| A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs M Poletti, C Logi, C Lucetti, P Del Dotto, F Baldacci, A Vergallo, M Ulivi, ... Journal of clinical psychopharmacology 33 (5), 691-694, 2013 | 115 | 2013 |
| Blood-based biomarkers for Alzheimer’s disease: Current state and future use in a transformed global healthcare landscape H Hampel, Y Hu, J Cummings, S Mattke, T Iwatsubo, A Nakamura, ... Neuron 111 (18), 2781-2799, 2023 | 111 | 2023 |
| Precision pharmacology for Alzheimer’s disease H Hampel, A Vergallo, LF Aguilar, N Benda, K Broich, AC Cuello, ... Pharmacological research 130, 331-365, 2018 | 105 | 2018 |
| The Alzheimer precision medicine initiative H Hampel, A Vergallo, G Perry, S Lista, ... Journal of Alzheimer’s Disease 68 (1), 1-24, 2019 | 103 | 2019 |
| Designing the next-generation clinical care pathway for Alzheimer’s disease H Hampel, R Au, S Mattke, WM van der Flier, P Aisen, L Apostolova, ... Nature Aging 2 (8), 692-703, 2022 | 102 | 2022 |
| Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 95 | 2018 |
| Rationale for early diagnosis of mild cognitive impairment (MCI) supported by emerging digital technologies MN Sabbagh, M Boada, S Borson, M Chilukuri, PM Doraiswamy, ... The Journal of Prevention of Alzheimer's Disease 7, 158-164, 2020 | 86 | 2020 |
| Migraine features in migraineurs with and without anxiety–depression symptoms: A hospital-based study F Baldacci, C Lucchesi, M Cafalli, M Poletti, M Ulivi, M Vedovello, ... Clinical neurology and neurosurgery 132, 74-78, 2015 | 86 | 2015 |
| microRNA-based biomarkers in Alzheimer’s disease (AD) Y Zhao, V Jaber, PN Alexandrov, A Vergallo, S Lista, H Hampel, WJ Lukiw Frontiers in neuroscience 14, 585432, 2020 | 85 | 2020 |